experimental autoimmune encephalitis
Recently Published Documents


TOTAL DOCUMENTS

58
(FIVE YEARS 14)

H-INDEX

15
(FIVE YEARS 2)

Author(s):  
Kerstin Renner ◽  
Sophia Neumayer ◽  
Yvonne Talke ◽  
Simone Buchtler ◽  
Kathrin Schmidbauer ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (17) ◽  
pp. 5227
Author(s):  
Annarita Del Gatto ◽  
Michele Saviano ◽  
Laura Zaccaro

Multiple sclerosis (MS) belongs to demyelinating diseases, which are progressive and highly debilitating pathologies that imply a high burden both on individual patients and on society. Currently, several treatment strategies differ in the route of administration, adverse events, and possible risks. Side effects associated with multiple sclerosis medications range from mild symptoms, such as flu-like or irritation at the injection site, to serious ones, such as progressive multifocal leukoencephalopathy and other life-threatening events. Moreover, the agents so far available have proved incapable of fully preventing disease progression, mostly during the phases that consist of continuous, accumulating disability. Thus, new treatment strategies, able to halt or even reverse disease progression and specific for targeting solely the pathways that contribute to the disease pathogenesis, are highly desirable. Here, we provide an overview of the recent literature about peptide-based systems tested on experimental autoimmune encephalitis (EAE) models. Since peptides are considered a unique therapeutic niche and important elements in the pharmaceutical landscape, they could open up new therapeutic opportunities for the treatment of MS.


Author(s):  
Hideyuki Takeuchi ◽  
Hiroshi Horiuchi ◽  
Bijay Parajuli ◽  
Hiroyasu Komiya ◽  
Fumiaki Tanaka ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Pinguang Yang ◽  
Hong Tian ◽  
Yong-Rui Zou ◽  
Pierre Chambon ◽  
Hiroshi Ichinose ◽  
...  

Epinephrine is a hormone secreted primarily by medullary cells of the adrenal glands which regulates permeability of blood–brain barrier (BBB). Recent studies showed signaling by epinephrine/epinephrine receptor in T cells is involved in autoimmune diseases. Nevertheless, the production of epinephrine by T cells and its pathogenic function in T cells are not well investigated. Our results show that phenylethanol N-methyltransferase (PNMT), a rate-limiting enzyme of epinephrine synthesis, is specifically expressed in vitro in differentiated TH17 cells and in tissue-resident TH17 cells. Indeed, expression levels of enzymes involved in epinephrine production are higher in TH17 cells from animals after EAE induction. The induction of PNMT was not observed in other effector T cell subsets or regulatory T cells. Epinephrine producing TH17 cells exhibit co-expression of GM-CSF, suggesting they are pathogenic TH17 cells. To delineate the function of epinephrine-production in TH17 cells, we generated a TH17-specific knockout of tyrosine hydroxylase (Th) by breeding a Th-flox and a ROR-gt-CRE mouse (Th-CKO). Th-CKO mice are developmentally normal with an equivalent T lymphocyte number in peripheral lymphoid organs. Th-CKO mice also show an equivalent number of TH17 cells in vivo and following in vitro differentiation. To test whether epinephrine-producing TH17 cells are key for breaching the BBB, migration of T cells through mouse brain endothelial cells was investigated in vitro. Both epi+ wild-type and epi- TH17 cells migrate through an endothelial cell barrier. Mice were immunized with MOG peptide to induce experimental autoimmune encephalitis (EAE) and disease progression was monitored. Although there is a reduced infiltration of CD4+ T cells in Th-CKO mice, no difference in clinical score was observed between Th-CKO and wild-type control mice. Increased neutrophils were observed in the central nervous system of Th-CKO mice, suggesting an alternative pathway to EAE progression in the absence of TH17 derived epinephrine.


Science ◽  
2020 ◽  
pp. eabb9818 ◽  
Author(s):  
Fiachra Humphries ◽  
Liraz Shmuel-Galia ◽  
Natalia Ketelut-Carneiro ◽  
Sheng Li ◽  
Bingwei Wang ◽  
...  

Activated macrophages undergo a metabolic switch to aerobic glycolysis accumulating Krebs cycle intermediates that alter transcription of immune response genes. Here we extend these observations by defining fumarate as an inhibitor of pyroptotic cell death. We found that dimethyl fumarate (DMF) delivered to cells or endogenous fumarate reacts with gasdermin D (GSDMD) at critical cysteine residues to form S-(2-succinyl)-cysteine. GSDMD succination prevents its interaction with caspases, limiting its processing, oligomerization, and capacity to induce cell death. In mice, the administration of DMF protects against LPS shock and alleviates familial Mediterranean fever and experimental autoimmune encephalitis (EAE) by targeting GSDMD. Collectively, these findings identify GSDMD as a target of fumarate and reveal a mechanism of action for fumarate-based therapeutics including DMF used to treat multiple sclerosis.


PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0234493
Author(s):  
Anne Skøttrup Mørkholt ◽  
Michal Krystian Oklinski ◽  
Agnete Larsen ◽  
Robert Bockermann ◽  
Shohreh Issazadeh-Navikas ◽  
...  

2020 ◽  
Vol 89 ◽  
pp. 102529
Author(s):  
Sylwia Wrotek ◽  
Anna Nowakowska ◽  
Michał Caputa ◽  
Wiesław Kozak

Sign in / Sign up

Export Citation Format

Share Document